These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 16219143

  • 1. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
    Zhou DH, Lin LZ, Zhou YQ, Luo RC, Liu KF, Jia YJ, Chen JY, Niu XW, Su BR, Lu J, Wang ST.
    Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
    [Abstract] [Full Text] [Related]

  • 2. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L.
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
    Song LH, Song XR, Liu MQ, Zhang XQ, Zheng L, Li XJ, Liu PX.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):345-8. PubMed ID: 15312344
    [Abstract] [Full Text] [Related]

  • 4. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ, Fernandes AL, Pereira JR, Curtis JR, Santoro IL.
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [Abstract] [Full Text] [Related]

  • 5. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF.
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [Abstract] [Full Text] [Related]

  • 6. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
    Liao ML, Zhou YZ, Ding JA, Ni GX, Zhao JM, Chen WH, Han BH, Shen J, Bai H, Chen ZW, Ji H, Wang HM, Zhou Z.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):962-6. PubMed ID: 12899797
    [Abstract] [Full Text] [Related]

  • 7. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
    Wakelee HA, Bernardo P, Johnson DH, Schiller JH.
    Cancer; 2006 May 15; 106(10):2208-17. PubMed ID: 16604529
    [Abstract] [Full Text] [Related]

  • 8. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov 15; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 9. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
    Cheng C, Wu YL, Gu LJ, Chen G, Weng YM, Feng WN, Zhong WZ.
    Ai Zheng; 2005 Jul 15; 24(7):846-9. PubMed ID: 16004813
    [Abstract] [Full Text] [Related]

  • 10. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
    Wei WD, Wen ZS, Su XD, Lin P, Rong TH, Chen LK.
    Ai Zheng; 2007 Nov 15; 26(11):1231-6. PubMed ID: 17991324
    [Abstract] [Full Text] [Related]

  • 11. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
    Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC.
    J Clin Oncol; 2004 Jul 01; 22(13):2594-601. PubMed ID: 15173214
    [Abstract] [Full Text] [Related]

  • 12. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.
    Dtsch Med Wochenschr; 2006 Nov 24; 131(47):2643-8. PubMed ID: 17109272
    [Abstract] [Full Text] [Related]

  • 13. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.
    Southeast Asian J Trop Med Public Health; 2005 Jul 24; 36(4):994-1006. PubMed ID: 16295558
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.
    Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R, Cetinayak HO, Sen RC, Demiral AN, Akkoçlu A, Osma E, Kargi A, Oztop I, Onen A, Kinay M, Dokuz Eylül Lung Cancer Study Group.
    J BUON; 2006 Sep 15; 11(1):31-7. PubMed ID: 17318949
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer].
    Wang YM, Guo LJ, Li LS, Li P, Zheng J, Li L.
    Ai Zheng; 2005 Dec 15; 24(12):1514-7. PubMed ID: 16351804
    [Abstract] [Full Text] [Related]

  • 17. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
    Stinchcombe TE, Morris DE, Moore DT, Bechtel JH, Halle JS, Mears A, Deschesne K, Rosenman JG, Socinski MA.
    Lung Cancer; 2006 Apr 15; 52(1):67-74. PubMed ID: 16499996
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep 15; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 19. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 15; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 20. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O, Ishii G, Kubota K, Murata Y, Naito Y, Mizuno T, Aokage K, Saijo N, Nishiwaki Y, Gemma A, Kudoh S, Ochiai A.
    Cancer; 2008 Sep 15; 113(6):1387-95. PubMed ID: 18671239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.